Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (391)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
483
8.370
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
80
3.610
 Why?
Immunologic Factors
13
2025
251
2.450
 Why?
Neurology
10
2018
113
2.220
 Why?
Immunosuppressive Agents
10
2024
859
1.540
 Why?
Neuromyelitis Optica
4
2023
139
1.100
 Why?
Natalizumab
11
2021
40
0.920
 Why?
Recurrence
8
2025
1114
0.870
 Why?
Diagnostic Errors
2
2017
177
0.680
 Why?
Brain
16
2025
2892
0.660
 Why?
Internship and Residency
5
2011
1250
0.630
 Why?
Drug Substitution
2
2019
63
0.620
 Why?
Fingolimod Hydrochloride
5
2020
43
0.620
 Why?
Rituximab
4
2020
206
0.580
 Why?
Data Collection
4
2011
655
0.580
 Why?
Dementia, Vascular
3
2009
21
0.570
 Why?
Medication Adherence
2
2019
515
0.530
 Why?
Early Medical Intervention
1
2017
60
0.510
 Why?
Early Diagnosis
2
2017
247
0.500
 Why?
Glatiramer Acetate
6
2019
18
0.490
 Why?
Magnetic Resonance Imaging
24
2025
3798
0.480
 Why?
Calcinosis
2
2009
238
0.480
 Why?
Humans
87
2025
143560
0.470
 Why?
Drug Monitoring
1
2019
396
0.460
 Why?
Physicians
4
2016
940
0.460
 Why?
Postural Balance
3
2018
247
0.430
 Why?
Antibodies, Monoclonal, Humanized
8
2023
927
0.410
 Why?
Fatigue
3
2018
349
0.370
 Why?
Dimethyl Fumarate
3
2020
12
0.360
 Why?
Immunoglobulin G
4
2023
898
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.320
 Why?
Middle Aged
39
2025
35342
0.320
 Why?
Practice Guidelines as Topic
1
2018
1557
0.320
 Why?
Withholding Treatment
2
2021
79
0.310
 Why?
Adult
43
2025
40013
0.300
 Why?
Psychiatry
2
2009
188
0.290
 Why?
Demyelinating Diseases
4
2019
83
0.280
 Why?
Cysts
1
2009
114
0.280
 Why?
HIV Long Terminal Repeat
3
2001
11
0.280
 Why?
Education, Medical
1
2011
276
0.270
 Why?
Autoantibodies
3
2023
1492
0.270
 Why?
Certification
1
2008
121
0.260
 Why?
Lymphopenia
2
2020
68
0.260
 Why?
Education
2
2007
107
0.260
 Why?
Central Nervous System Cysts
1
2006
13
0.250
 Why?
Female
49
2025
77251
0.250
 Why?
Clinical Trials as Topic
3
2016
1043
0.250
 Why?
Cerebral Arteries
1
2006
59
0.250
 Why?
Single-Blind Method
3
2023
294
0.240
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
55
0.240
 Why?
Male
40
2025
71500
0.240
 Why?
Cerebrovascular Disorders
1
2006
100
0.240
 Why?
DNA, Viral
2
1998
366
0.230
 Why?
Ethics, Medical
2
2015
83
0.230
 Why?
Drug Industry
2
2016
48
0.230
 Why?
Societies, Medical
4
2019
873
0.230
 Why?
Conflict of Interest
2
2016
48
0.230
 Why?
HIV Seropositivity
2
1998
119
0.220
 Why?
Treatment Outcome
12
2023
11365
0.220
 Why?
Databases, Factual
3
2016
1465
0.210
 Why?
Double-Blind Method
4
2023
2017
0.210
 Why?
AIDS Dementia Complex
3
2001
52
0.200
 Why?
Microglia
2
2024
257
0.190
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
68
0.190
 Why?
Heart Aneurysm
1
2002
12
0.190
 Why?
Quality of Health Care
2
2017
650
0.180
 Why?
Heart Septal Defects, Atrial
1
2002
60
0.180
 Why?
B-Lymphocytes
5
2023
884
0.180
 Why?
Interferon beta-1a
2
2019
14
0.170
 Why?
Lymphoma
2
2005
228
0.170
 Why?
Education, Medical, Continuing
2
2015
128
0.170
 Why?
Neuroimaging
1
2023
282
0.170
 Why?
Mental Disorders
2
2007
1151
0.170
 Why?
Central Nervous System Neoplasms
2
2005
172
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Brain Neoplasms
4
2016
1300
0.160
 Why?
Interferon-gamma
1
2023
791
0.160
 Why?
Serum Sickness
1
2019
5
0.160
 Why?
Indans
1
2019
12
0.150
 Why?
Neutropenia
1
2020
152
0.150
 Why?
Oxadiazoles
1
2019
36
0.150
 Why?
Disease Progression
4
2021
2856
0.150
 Why?
Diagnosis, Differential
4
2023
1504
0.150
 Why?
Referral and Consultation
1
2005
828
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Adjuvants, Immunologic
3
2015
240
0.140
 Why?
Salvage Therapy
1
2019
156
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
257
0.140
 Why?
Herpesvirus 8, Human
1
1998
66
0.130
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.130
 Why?
Educational Measurement
3
2015
324
0.130
 Why?
Eye Movements
1
2018
92
0.130
 Why?
Physician-Patient Relations
2
2016
589
0.130
 Why?
Central Nervous System
2
2005
269
0.130
 Why?
Sarcoma, Kaposi
1
1998
83
0.130
 Why?
Patient Selection
2
2015
691
0.130
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
676
0.130
 Why?
Herpesvirus 4, Human
1
2018
169
0.130
 Why?
Young Adult
7
2024
13972
0.130
 Why?
Nervous System Diseases
2
2024
280
0.130
 Why?
Herpesviridae Infections
1
1998
148
0.130
 Why?
Suicide, Assisted
1
1997
28
0.120
 Why?
Neurologists
1
2016
22
0.120
 Why?
Costs and Cost Analysis
1
2017
220
0.120
 Why?
Estriol
1
2015
6
0.120
 Why?
Cost-Benefit Analysis
2
2016
621
0.120
 Why?
Aged
9
2024
25322
0.120
 Why?
Dizziness
2
2018
95
0.110
 Why?
Corpus Callosum
2
2006
72
0.110
 Why?
Verbal Learning
2
2013
67
0.110
 Why?
Retrospective Studies
10
2024
16741
0.110
 Why?
T-Lymphocytes
1
2023
2026
0.110
 Why?
Follow-Up Studies
6
2020
5308
0.110
 Why?
Trust
1
2016
147
0.110
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
156
0.110
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
60
0.100
 Why?
Medication Reconciliation
1
2013
30
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
135
0.100
 Why?
CD40 Antigens
1
2014
91
0.100
 Why?
Insurance, Health
1
2016
299
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Exercise Therapy
1
2018
459
0.100
 Why?
Stroke
1
2002
1213
0.100
 Why?
Anti-Inflammatory Agents
2
2006
482
0.100
 Why?
Sensation Disorders
1
2012
41
0.090
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
19
0.090
 Why?
Population Surveillance
1
2016
488
0.090
 Why?
Memory Disorders
1
2013
185
0.090
 Why?
Immunoglobulin Heavy Chains
3
2007
85
0.090
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.090
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
20
0.090
 Why?
HIV-1
2
2001
892
0.090
 Why?
Optic Nerve
2
2005
66
0.090
 Why?
T-Lymphocyte Subsets
1
2014
422
0.090
 Why?
Glioma
1
2016
425
0.090
 Why?
Gadolinium
4
2018
86
0.090
 Why?
United States
8
2024
15553
0.080
 Why?
Academies and Institutes
1
2011
61
0.080
 Why?
Self-Assessment
1
2011
75
0.080
 Why?
Learning
1
2015
436
0.080
 Why?
Nerve Regeneration
1
2010
58
0.080
 Why?
Fatal Outcome
3
2006
313
0.080
 Why?
Diagnostic Tests, Routine
1
2011
110
0.080
 Why?
Leukocytosis
1
2010
33
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
8
0.080
 Why?
Hemangioma, Cavernous
1
1989
14
0.080
 Why?
Antigens, CD19
3
2007
138
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Biomarkers
3
2014
4241
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Exercise Test
1
2012
624
0.080
 Why?
Quality of Life
3
2021
3080
0.080
 Why?
Severity of Illness Index
3
2014
2936
0.080
 Why?
Disease Management
1
2013
646
0.070
 Why?
Guidelines as Topic
1
2011
270
0.070
 Why?
Spinal Cord
3
2023
379
0.070
 Why?
Neuroprotective Agents
1
2009
142
0.070
 Why?
Physical Therapy Modalities
1
2011
324
0.070
 Why?
Hospital-Physician Relations
1
2007
3
0.070
 Why?
Immunoglobulin Variable Region
2
2004
81
0.070
 Why?
Workload
1
2009
164
0.060
 Why?
Practice Patterns, Physicians'
1
2016
1362
0.060
 Why?
Vasculitis, Central Nervous System
1
2006
15
0.060
 Why?
Neuropsychological Tests
2
2013
1099
0.060
 Why?
Headache Disorders
1
2006
19
0.060
 Why?
CD4-Positive T-Lymphocytes
1
1993
1130
0.060
 Why?
Nerve Fibers, Myelinated
1
2006
47
0.060
 Why?
Antibodies, Monoclonal
2
2011
1474
0.060
 Why?
Methylprednisolone
1
2006
64
0.060
 Why?
Medical Records
1
2007
185
0.060
 Why?
Syndrome
2
2023
379
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
112
0.060
 Why?
Antibody Formation
1
2007
297
0.060
 Why?
International Classification of Diseases
1
2007
142
0.060
 Why?
Huntington Disease
1
2007
64
0.060
 Why?
Contrast Media
3
2018
479
0.060
 Why?
Herpes Zoster
1
2010
319
0.060
 Why?
Intracranial Hemorrhages
1
2006
99
0.060
 Why?
Aquaporin 4
1
2006
100
0.060
 Why?
DNA Mutational Analysis
1
2006
404
0.060
 Why?
Adolescent
8
2024
22481
0.060
 Why?
Canada
2
2019
433
0.060
 Why?
Health Care Surveys
1
2007
565
0.060
 Why?
Fellowships and Scholarships
1
2009
333
0.060
 Why?
Cognition Disorders
1
2009
523
0.060
 Why?
Analysis of Variance
3
2015
1314
0.060
 Why?
Neurologic Examination
1
2005
127
0.060
 Why?
Teaching
1
2007
233
0.050
 Why?
RNA, Messenger
1
1992
2852
0.050
 Why?
Patient Compliance
1
2009
617
0.050
 Why?
Program Evaluation
1
2009
937
0.050
 Why?
Surveys and Questionnaires
4
2016
6025
0.050
 Why?
Affect
1
2007
315
0.050
 Why?
Central Nervous System Diseases
1
2005
73
0.050
 Why?
Erythrocytes
1
2010
708
0.050
 Why?
Colorado
2
2024
4658
0.050
 Why?
Neutrophils
1
2010
1134
0.050
 Why?
Simvastatin
1
2004
62
0.050
 Why?
Proteoglycans
1
2004
109
0.050
 Why?
Ophthalmoplegia
1
2003
13
0.050
 Why?
Prevalence
2
2024
2830
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
53
0.050
 Why?
Faculty, Medical
1
2006
297
0.050
 Why?
B-Lymphocyte Subsets
1
2003
79
0.050
 Why?
Cyclophosphamide
1
2003
259
0.050
 Why?
Radiography
1
2005
846
0.050
 Why?
Neurodegenerative Diseases
1
2024
143
0.050
 Why?
Academic Medical Centers
1
2005
535
0.050
 Why?
Infusions, Intravenous
1
2023
423
0.040
 Why?
Patient Outcome Assessment
1
2023
132
0.040
 Why?
Membrane Glycoproteins
1
2004
498
0.040
 Why?
Lymphoma, B-Cell
2
2005
133
0.040
 Why?
Students, Medical
1
2006
372
0.040
 Why?
Induced Pluripotent Stem Cells
1
2024
272
0.040
 Why?
Pain
1
2007
781
0.040
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.040
 Why?
Anticoagulants
1
2006
728
0.040
 Why?
Molecular Sequence Data
3
2004
2942
0.040
 Why?
Disability Evaluation
2
2014
304
0.040
 Why?
Single-Cell Analysis
1
2024
354
0.040
 Why?
Peptides
3
2013
976
0.040
 Why?
Cross-Sectional Studies
1
2012
5743
0.040
 Why?
Antibodies, Antinuclear
1
2001
67
0.040
 Why?
Schools, Medical
1
2002
158
0.040
 Why?
Dementia
1
2005
292
0.040
 Why?
Atrophy
1
2021
197
0.040
 Why?
Time Factors
4
2018
7031
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
160
0.040
 Why?
Mobility Limitation
1
2020
63
0.040
 Why?
Clinical Competence
1
2008
1235
0.040
 Why?
Venous Thrombosis
1
2002
194
0.040
 Why?
Child
5
2016
22725
0.040
 Why?
Interferon-beta
2
2011
94
0.040
 Why?
Lymphocyte Activation
1
2003
1143
0.040
 Why?
Antibodies, Viral
1
2023
666
0.040
 Why?
Maintenance Chemotherapy
1
2019
40
0.040
 Why?
Cerebral Infarction
1
1998
49
0.040
 Why?
Cell Separation
2
2014
311
0.040
 Why?
Induction Chemotherapy
1
2019
84
0.040
 Why?
Lipids
1
2023
704
0.030
 Why?
HIV Seronegativity
1
1998
30
0.030
 Why?
Genes, myc
1
1998
51
0.030
 Why?
Base Sequence
2
2001
2199
0.030
 Why?
Transplantation, Autologous
1
2019
284
0.030
 Why?
Astrocytoma
1
1998
130
0.030
 Why?
In Situ Hybridization
1
2018
321
0.030
 Why?
Gene Library
1
1997
123
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
346
0.030
 Why?
Gene Rearrangement
1
1998
150
0.030
 Why?
Risk Assessment
1
2006
3577
0.030
 Why?
Syndecan-1
2
2007
41
0.030
 Why?
Managed Care Programs
1
1997
140
0.030
 Why?
Drug Administration Schedule
1
2018
773
0.030
 Why?
Breast Neoplasms
1
2008
2318
0.030
 Why?
Morals
1
1997
77
0.030
 Why?
Flow Cytometry
2
2014
1192
0.030
 Why?
Viral Load
1
2018
514
0.030
 Why?
Risk Factors
3
2008
10644
0.030
 Why?
Mutation
1
2006
4053
0.030
 Why?
Survival Analysis
1
2018
1332
0.030
 Why?
Polymerase Chain Reaction
1
1998
1062
0.030
 Why?
Sequence Analysis, DNA
1
1997
823
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1413
0.030
 Why?
Child, Preschool
3
2016
11737
0.030
 Why?
Incidence
1
2020
2844
0.030
 Why?
Congresses as Topic
1
2015
226
0.020
 Why?
Patient Care Team
1
2019
690
0.020
 Why?
Propylene Glycols
1
2013
28
0.020
 Why?
Ocular Physiological Phenomena
1
1992
10
0.020
 Why?
HLA-DR Antigens
1
2014
223
0.020
 Why?
Sphingosine
1
2013
47
0.020
 Why?
Quality-Adjusted Life Years
1
2013
113
0.020
 Why?
beta-Galactosidase
1
1992
78
0.020
 Why?
Markov Chains
1
2013
126
0.020
 Why?
Drug Therapy, Combination
1
2015
1058
0.020
 Why?
Leukocyte Count
1
1993
317
0.020
 Why?
Mice, Inbred DBA
1
1992
200
0.020
 Why?
Haplotypes
1
2014
496
0.020
 Why?
Organ Specificity
1
1992
311
0.020
 Why?
Reference Values
1
2013
811
0.020
 Why?
Comparative Effectiveness Research
1
2013
164
0.020
 Why?
CD3 Complex
1
2012
107
0.020
 Why?
Ki-67 Antigen
1
2012
114
0.020
 Why?
Mental Recall
1
2013
213
0.020
 Why?
Thymus Gland
1
1992
319
0.020
 Why?
Intestine, Small
1
1992
159
0.020
 Why?
Mitoxantrone
1
2011
14
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Mice
2
2023
18378
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Animals
3
2023
38010
0.020
 Why?
Patient Participation
1
2015
434
0.020
 Why?
Clinical Laboratory Techniques
1
2011
97
0.020
 Why?
Depression
2
2011
1512
0.020
 Why?
Recombinant Fusion Proteins
1
1992
677
0.020
 Why?
Amino Acid Sequence
2
2004
2165
0.020
 Why?
Physical Endurance
1
2011
278
0.020
 Why?
Acyclovir
1
2010
96
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Cell Count
1
2010
323
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1671
0.020
 Why?
History, 19th Century
1
2009
61
0.020
 Why?
Respiratory Function Tests
1
2011
560
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
59
0.020
 Why?
Aged, 80 and over
2
2016
8072
0.020
 Why?
Injections
1
2009
195
0.020
 Why?
History, 21st Century
1
2009
220
0.020
 Why?
Pilot Projects
2
2004
1838
0.020
 Why?
Electrocardiography
1
2011
630
0.020
 Why?
Autoimmunity
1
2014
927
0.020
 Why?
History, 20th Century
1
2009
327
0.020
 Why?
Gene Expression
1
1992
1505
0.020
 Why?
Mice, Transgenic
1
1992
2194
0.020
 Why?
Age of Onset
1
2009
548
0.020
 Why?
Health
1
2007
83
0.020
 Why?
Memory
1
2009
266
0.020
 Why?
Association Learning
1
2007
63
0.020
 Why?
Herpesvirus 3, Human
1
2010
336
0.020
 Why?
Cerebral Ventricles
1
2006
54
0.020
 Why?
Walking
1
2011
557
0.020
 Why?
Prognosis
2
2006
4152
0.020
 Why?
Motor Skills
1
2007
105
0.010
 Why?
CD8-Positive T-Lymphocytes
1
2012
928
0.010
 Why?
Hypothalamus
1
2006
154
0.010
 Why?
Genetics
1
2005
24
0.010
 Why?
Phenotype
1
2014
3211
0.010
 Why?
Models, Theoretical
1
2009
586
0.010
 Why?
Immunologic Memory
1
2007
365
0.010
 Why?
Neurosciences
1
2005
25
0.010
 Why?
Hospitalization
1
2015
2313
0.010
 Why?
Social Support
1
2009
635
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Anisotropy
1
2004
77
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
277
0.010
 Why?
Clinical Protocols
1
2006
279
0.010
 Why?
Internet
1
2009
698
0.010
 Why?
Immune System
1
2005
183
0.010
 Why?
Plasma Cells
1
2004
74
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
12
0.010
 Why?
Antiviral Agents
1
2010
764
0.010
 Why?
Infrared Rays
1
2003
26
0.010
 Why?
Meningitis, Viral
1
2003
20
0.010
 Why?
Videotape Recording
1
2003
39
0.010
 Why?
Antilymphocyte Serum
1
2003
59
0.010
 Why?
Saccades
1
2003
45
0.010
 Why?
Oligoclonal Bands
1
2003
25
0.010
 Why?
Antigens, CD34
1
2003
88
0.010
 Why?
Whole-Body Irradiation
1
2003
77
0.010
 Why?
Clone Cells
1
2003
270
0.010
 Why?
Astrocytes
1
2005
219
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
135
0.010
 Why?
Immunoglobulins
1
2003
162
0.010
 Why?
Observer Variation
1
2003
361
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
190
0.010
 Why?
Feasibility Studies
1
2006
1051
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
9
0.010
 Why?
Administration, Oral
1
2004
842
0.010
 Why?
Mice, Inbred C57BL
1
1992
6043
0.010
 Why?
Age Factors
1
2009
3328
0.010
 Why?
Consensus Sequence
1
2001
75
0.010
 Why?
Biopsy
1
2005
1083
0.010
 Why?
Cytomegalovirus Infections
1
2003
199
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2779
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
994
0.010
 Why?
Longitudinal Studies
1
2009
3006
0.010
 Why?
Sex Characteristics
1
2007
793
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
23
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
56
0.010
 Why?
Urinary Tract Infections
1
2003
200
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
100
0.010
 Why?
Infant
1
2015
9981
0.010
 Why?
Predictive Value of Tests
1
2006
2086
0.010
 Why?
Cohort Studies
1
2011
5891
0.010
 Why?
Acute Disease
1
2003
1015
0.010
 Why?
Research
1
2003
438
0.010
 Why?
Combined Modality Therapy
1
2003
1252
0.010
 Why?
Lung
1
1992
4101
0.010
 Why?
Arachnoid
1
1998
12
0.010
 Why?
Sensitivity and Specificity
1
2003
1984
0.010
 Why?
Survival Rate
1
2003
2003
0.010
 Why?
Monocytes
1
2001
545
0.010
 Why?
Virus Replication
1
2001
544
0.010
 Why?
Binding Sites
1
2001
1325
0.010
 Why?
Models, Biological
1
2005
1831
0.010
 Why?
Case-Control Studies
1
2004
3625
0.010
 Why?
Aging
1
2007
1946
0.010
 Why?
Reproducibility of Results
1
2003
3380
0.010
 Why?
Transcription, Genetic
1
2001
1511
0.010
 Why?
DNA-Binding Proteins
1
2001
1524
0.010
 Why?
Cells, Cultured
1
2001
4182
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (391) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)